Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial. [PDF]
Ali NO +4 more
europepmc +1 more source
Allopurinol Use Is Associated with Decreased Incidence of Hepatic Decompensation and Overall Mortality among Individuals with Cirrhosis: A Propensity-Matched Cohort Study. [PDF]
Al Hayek M +13 more
europepmc +1 more source
Allopurinol Reprograms Uric Acid Self-Assembly by Disrupting Cytotoxic Fibrils and Redirecting Crystal Growth. [PDF]
Laor Bar-Yosef D +9 more
europepmc +1 more source
Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. [PDF]
McCormick N +10 more
europepmc +1 more source
Assessing willingness to pay for HLA-B*58:01 genetic testing before allopurinol initiation and its potential impact on future health policy, Thailand. [PDF]
Towiwat P +4 more
europepmc +1 more source
Dose-Sparing Efficacy of d-Limonene with Low-Dose Allopurinol in a Dual Model of Hyperuricemia and Gouty Arthritis in Rats. [PDF]
Venkatesan K +11 more
europepmc +1 more source
Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]
Doménech-Serrano J +5 more
europepmc +1 more source
Gout prevalence and management strategies among patients with moderate to advanced chronic kidney disease. [PDF]
Sylvertooth D +5 more
europepmc +1 more source
Rasburicase vs. allopurinol: mortality in hematological malignancies post anti-hyperuricemic therapy - real-world study. [PDF]
Cairo MS +5 more
europepmc +1 more source
A Systematic Review of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology and Treatment Strategies. [PDF]
Wang B +5 more
europepmc +1 more source

